We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours (CC) Tops Earnings and Revenue Estimates in Q4
Read MoreHide Full Article
The Chemours Company (CC - Free Report) swung to a profit of $19 million or 11 cents per share in the fourth quarter of 2020 from a loss of $317 million or $1.94 per share in the year-ago quarter.
Adjusted earnings were 61 cents per share for the quarter, which surpassed the Zacks Consensus Estimate of 36 cents.
Net sales fell around 1% year over year to $1,300 million. It beat the Zacks Consensus Estimate of $1,250.6 million. Sales for the quarter included a 2% portfolio impact from the divested MAP business.
Sales rose 8% on a sequential comparison basis as a global macroeconomic recovery led to higher sales in Titanium Technologies, Advanced Performance Materials and Chemicals Solutions units. Strong sequential volume growth was partly offset by lower global average prices.
The Chemours Company Price, Consensus and EPS Surprise
The Titanium Technologies division raked in revenues of $691 million in the quarter, up around 13% year over year. Volumes rose 17% year over year on a demand recovery in architectural coatings, laminates and plastics markets. Global average selling prices fell 6% year over year.
Revenues in the Thermal & Specialized Solutions (formerly known as Fluoroproducts) segment fell roughly 6% year over year to $272 million in the reported quarter. Volumes were flat while prices declined 7% year over year. The company saw higher Opteon volume from sustained adoption in stationary applications and in the automotive aftermarket.
Revenues in the Advanced Performance Materials unit (formerly known as Fluoropolymers) were $279 million, down around 14% year over year. Volume fell 10% while price dropped 6% year over year. The company witnessed sustained demand weakness as a result of the pandemic. However, the impact moderated as the recovery gained momentum in its major end markets.
The Chemical Solutions unit recorded sales of $95 million, down 26% year over year. Prices and volumes fell year over year. The divesture of the MAP business led to a 21% impact on a year-over-year basis.
FY20 Results
Earnings (as reported) for full-year 2020 were $1.32 per share, compared with a loss of 32 cents per share a year ago. Revenues dropped roughly 10% year over year to $5 billion for the full year.
Financials
Chemours ended 2020 with cash and cash equivalents of $1,105 million, up roughly 17% year over year. Long-term debt was $4,005 million, down around 1% year over year.
Cash provided by operating activities was $807 million in 2020 while free cash flow was $540 million.
Outlook
Chemours expects adjusted EBITDA in the band of $1-$1.15 billion in 2021. It also sees adjusted earnings per share of between $2.40 and $3.12 for the year. Capital expenditures are forecast to be roughly $350 million in 2021. The company also expects free cash flow of more than $350 million for the year.
Price Performance
Chemours’ shares have rallied 76.4% in the past year compared with a 16.6% rise recorded by its industry.
Zacks Rank & Key Picks
Chemours currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks worth considering in the basic materials space include Fortescue Metals Group Limited (FSUGY - Free Report) , Impala Platinum Holdings Limited (IMPUY - Free Report) and New Gold Inc. (NGD - Free Report) .
Fortescue has a projected earnings growth rate of 78.4% for the current fiscal. The company’s shares have surged around 147% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 189.4% for the current fiscal. The company’s shares have rallied around 57% in the past year. It currently carries a Zacks Rank #1.
New Gold has a projected earnings growth rate of 733.3% for the current year. The company’s shares have shot up around 107% in a year. It currently carries a Zacks Rank #2.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
Chemours (CC) Tops Earnings and Revenue Estimates in Q4
The Chemours Company (CC - Free Report) swung to a profit of $19 million or 11 cents per share in the fourth quarter of 2020 from a loss of $317 million or $1.94 per share in the year-ago quarter.
Adjusted earnings were 61 cents per share for the quarter, which surpassed the Zacks Consensus Estimate of 36 cents.
Net sales fell around 1% year over year to $1,300 million. It beat the Zacks Consensus Estimate of $1,250.6 million. Sales for the quarter included a 2% portfolio impact from the divested MAP business.
Sales rose 8% on a sequential comparison basis as a global macroeconomic recovery led to higher sales in Titanium Technologies, Advanced Performance Materials and Chemicals Solutions units. Strong sequential volume growth was partly offset by lower global average prices.
The Chemours Company Price, Consensus and EPS Surprise
The Chemours Company price-consensus-eps-surprise-chart | The Chemours Company Quote
Segment Highlights
The Titanium Technologies division raked in revenues of $691 million in the quarter, up around 13% year over year. Volumes rose 17% year over year on a demand recovery in architectural coatings, laminates and plastics markets. Global average selling prices fell 6% year over year.
Revenues in the Thermal & Specialized Solutions (formerly known as Fluoroproducts) segment fell roughly 6% year over year to $272 million in the reported quarter. Volumes were flat while prices declined 7% year over year. The company saw higher Opteon volume from sustained adoption in stationary applications and in the automotive aftermarket.
Revenues in the Advanced Performance Materials unit (formerly known as Fluoropolymers) were $279 million, down around 14% year over year. Volume fell 10% while price dropped 6% year over year. The company witnessed sustained demand weakness as a result of the pandemic. However, the impact moderated as the recovery gained momentum in its major end markets.
The Chemical Solutions unit recorded sales of $95 million, down 26% year over year. Prices and volumes fell year over year. The divesture of the MAP business led to a 21% impact on a year-over-year basis.
FY20 Results
Earnings (as reported) for full-year 2020 were $1.32 per share, compared with a loss of 32 cents per share a year ago. Revenues dropped roughly 10% year over year to $5 billion for the full year.
Financials
Chemours ended 2020 with cash and cash equivalents of $1,105 million, up roughly 17% year over year. Long-term debt was $4,005 million, down around 1% year over year.
Cash provided by operating activities was $807 million in 2020 while free cash flow was $540 million.
Outlook
Chemours expects adjusted EBITDA in the band of $1-$1.15 billion in 2021. It also sees adjusted earnings per share of between $2.40 and $3.12 for the year. Capital expenditures are forecast to be roughly $350 million in 2021. The company also expects free cash flow of more than $350 million for the year.
Price Performance
Chemours’ shares have rallied 76.4% in the past year compared with a 16.6% rise recorded by its industry.
Zacks Rank & Key Picks
Chemours currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks worth considering in the basic materials space include Fortescue Metals Group Limited (FSUGY - Free Report) , Impala Platinum Holdings Limited (IMPUY - Free Report) and New Gold Inc. (NGD - Free Report) .
Fortescue has a projected earnings growth rate of 78.4% for the current fiscal. The company’s shares have surged around 147% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 189.4% for the current fiscal. The company’s shares have rallied around 57% in the past year. It currently carries a Zacks Rank #1.
New Gold has a projected earnings growth rate of 733.3% for the current year. The company’s shares have shot up around 107% in a year. It currently carries a Zacks Rank #2.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2021 today >>